Cancer biotherapy: review and prospect
Clinical and Experimental Medicine · 2024
DOI: 10.1007/s10238-024-01376-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Experimental Medicine, 2024. Verfasst von Qi Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Zunyi Medical University, Zunyi, Guizhou, 563000, China. Hauptthemen laut MEDLINE: Neoplasms, Biological Therapy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 2021 Graduate Research Fund Projects under grant, the Guizhou Provincial Department of Science and Technology, the Guizhou Provincial Administration of Traditional Chinese Medicine.
Abstract (Originalsprache)
Malignant tumors pose a grave threat to the quality of human life. The prevalence of malignant tumors in China is steadily rising. Presently, clinical interventions encompass surgery, radiotherapy, and pharmaceutical therapy in isolation or combination. Nonetheless, these modalities fail to completely eradicate malignant tumor cells, frequently leading to metastasis and recurrence. Conversely, tumor biotherapy has emerged as an encouraging fourth approach in preventing and managing malignant tumors owing to its safety, efficacy, and minimal adverse effects. Currently, a range of tumor biotherapy techniques are employed, including gene therapy, tumor vaccines, monoclonal antibody therapy, cancer stem cell therapy, cytokine therapy, and adoptive cellular immunotherapy. This study aims to comprehensively review the latest developments in biological treatments for malignant tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zunyi Medical University, Zunyi, Guizhou, 563000, China.
- Department of Thoracic Oncology, The Second Affiliated Hospital of Zunyi Medical University, Guizhou, 56300, Zunyi, China.
- Zunyi Medical University, Zunyi, Guizhou, 563000, China. mahuab@163.com.
- Department of Thoracic Oncology, The Second Affiliated Hospital of Zunyi Medical University, Guizhou, 56300, Zunyi, China. mahuab@163.com.
Förderung
- 2021 Graduate Research Fund Projects under grant
- the Guizhou Provincial Department of Science and Technology
- the Guizhou Provincial Administration of Traditional Chinese Medicine
Zitieren
APA
Liu, Q., & Ma, H. (2024). Cancer biotherapy: review and prospect. Clinical and Experimental Medicine. https://doi.org/10.1007/s10238-024-01376-2
Vancouver
Liu Q, Ma H. Cancer biotherapy: review and prospect. Clinical and Experimental Medicine. 2024. doi:10.1007/s10238-024-01376-2
BibTeX
@article{Liu2024,
author = {Liu, Qi and Ma, Hu},
title = {Cancer biotherapy: review and prospect},
journal = {Clinical and Experimental Medicine},
year = {2024},
doi = {10.1007/s10238-024-01376-2}
}
EUVIMED